(Q28308033)
Statements
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients (English)
0 references
February 2009
0 references
157
0 references
352-360.e2
0 references
2
0 references